Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Jianyun Wen"'
Autor:
Yongsheng Ruan, Libai Chen, Tingting Luo, Danfeng Xie, Wei Cao, Xuan Liu, Qiujun Liu, Yuhua Xiao, Cuiling Wu, Jianyun Wen, Juan Li, Jiangnan Meng, Xuedong Wu, Xiaoqin Feng
Publikováno v:
Infectious Diseases and Therapy, Vol 12, Iss 8, Pp 2071-2086 (2023)
Abstract Introduction Since hematopoietic stem cell transplant (HSCT) is an important therapy for malignant and non-malignant pediatric diseases, improving transplant-related mortality remains a challenge. Currently, rituximab, a monoclonal antibody
Externí odkaz:
https://doaj.org/article/430a2f50f5da4ae0b462ff8d5e77997c
Autor:
Jianyun WEN, Libai CHEN, Jing DU, Xiaoxiao XU, Yuelin HE, Yongsheng RUAN, Xiu LI, Juan LI, Xuedong WU
Publikováno v:
Zhongguo shuxue zazhi, Vol 36, Iss 6, Pp 500-504 (2023)
Objective To evaluate the safety and efficacy of the collection of peripheral blood stem cells (PBSCs) in pediatric patients with thalassemia major (TM) weighing 20 kg or less. Methods PBSCs collection data of 170 pediatric patients with TM weighing
Externí odkaz:
https://doaj.org/article/8daf46a1c51843c09479c449855d90cd
Autor:
Jianyun Wen, Xiaodong Wang, Libai Chen, Yuelin He, Xiaoqin Feng, Chunfu Li, Yongshen Ruan, Sixi Liu, Xuedong Wu
Publikováno v:
Hematology, Vol 27, Iss 1, Pp 310-317 (2022)
Background Allogeneic haematopoietic stem cell transplantation (allo-HSCT) is currently the only curative treatment for thalassaemia major (TM). Cord blood (CB) from a sibling has different characteristics from marrow and has potential advantages and
Externí odkaz:
https://doaj.org/article/98e6594769f14e3a9ccab826f116de9e
Autor:
Yongsheng Ruan, Tingting Luo, Qiujun Liu, Xuan Liu, Libai Chen, Jianyun Wen, Yuhua Xiao, Danfeng Xie, Yuelin He, Xuedong Wu, Xiaoqin Feng
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 12 (2022)
Cytomegalovirus (CMV) infection remains a critical cause of mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT), despite improvement by pre-emptive antivirus treatment. CMV-specific cytotoxic T lymphocytes (CMV-CTL) are uni
Externí odkaz:
https://doaj.org/article/b9672d22fad849258f086362f63a4e1c
Autor:
Xiaoping Liu, Libin Huang, Ke Huang, Lihua Yang, Xu Yang, Ailing Luo, Mansi Cai, Xuedong Wu, Xiaodan Liu, Yaping Yan, Jianyun Wen, Yun Cai, Ling Xu, Hua Jiang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
ObjectiveTo reveal the contributing role of METTL3 gene SNPs in pediatric ALL risk.Patients and MethodsA total of 808 pediatric ALL cases and 1,340 cancer-free controls from five hospitals in South China were recruited. A case-control study by genoty
Externí odkaz:
https://doaj.org/article/924b47c295a842f3a3db193473a2f24b
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: Human glypican-3 (hGPC3) is a protein highly expressed in hepatocellular carcinoma (HCC) but limited in normal tissues, making it an ideal target for immunotherapy. The adoptive transfer of hGPC3-specific chimeric antigen receptor T (CAR-
Externí odkaz:
https://doaj.org/article/d3a4f7de2c6347dab23c36e60250b7a1
Autor:
Jieming, Yu, Tiantian, Yi, Guanchuan, Lin, Jianyun, Wen, Libai, Chen, Jiaqi, Chen, Xuedong, Wu
Publikováno v:
Nan fang yi ke da xue xue bao = Journal of Southern Medical University. 40(2)
OBJECTIVE: To assess the prognostic value of minimal residual disease on 19th day of induction chemotherapy (D19 MRD) and the risk factors of D19 MRD ≥ 1% in children with acute lymphoblastic leukemia (ALL) treated following the Chinese Children's
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology
Background: Human glypican-3 (hGPC3) is a protein highly expressed in hepatocellular carcinoma (HCC) but limited in normal tissues, making it an ideal target for immunotherapy. The adoptive transfer of hGPC3-specific chimeric antigen receptor T (CAR-
Autor:
Liu, Xuan, Jianyun Wen, Honglei Yi, Xiaorui Hou, Yin, Yue, Guofu Ye, Xuedong Wu, Xiaotao Jiang
Supplemental material, Table_S1 for Split chimeric antigen receptor-modified T cells targeting glypican-3 suppress hepatocellular carcinoma growth with reduced cytokine release by Xuan Liu, Jianyun Wen, Honglei Yi, Xiaorui Hou, Yue Yin, Guofu Ye, Xue
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a63e3fcd9ec97e3dde505281faadc41
Autor:
Xiaoqin Feng, Libai Chen, Jianyun Wen, Yongsheng Ruan, Yue-lin He, Chunfu Li, Xuan Liu, Fuyu Pei, Xuedong Wu, Qareen Haque
Publikováno v:
Acta Haematologica. 140:20-29
Background: Hematopoietic stem cell transplantation (HSCT) is currently the only curative treatment for thalassemia majorTM. Graft rejection (GR) and graft-versus-host disease (GVHD) are the primary obstacles to a successful outcome. Methods: We cond